Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

TTOO

T2 Biosystems Inc

Apr 18 • 02:24PM ET

2.94

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-145.61	Insider Own	31.36%	Shs Outstand	4.06M	Perf Week	-6.67%
Market Cap	16.20M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.78M	Perf Month	-15.76%
Income	-50.08M	PEG	-	EPS next Q	-2.27	Inst Own	3.96%	Short Float	10.50%	Perf Quarter	-34.67%
Sales	7.19M	P/S	2.25	EPS this Y	65.66%	Inst Trans	42.61%	Short Ratio	1.60	Perf Half Y	-61.06%
Book/sh	-6.91	P/B	-	EPS next Y	-	ROA	-144.89%	Short Interest	0.40M	Perf Year	-92.14%
Cash/sh	2.85	P/C	1.03	EPS next 5Y	-	ROE	-	52W Range	2.70 - 70.00	Perf YTD	-53.15%
Dividend Est.	-	P/FCF	-	EPS past 5Y	68.62%	ROI	-	52W High	-95.80%	Beta	0.09
Dividend TTM	-	Quick Ratio	0.36	Sales past 5Y	12.68%	Gross Margin	-117.39%	52W Low	8.89%	ATR (14)	0.35
Dividend Ex-Date	-	Current Ratio	0.45	EPS Y/Y TTM	89.82%	Oper. Margin	-655.54%	RSI (14)	37.13	Volatility	10.56% 11.76%
Employees	113	Debt/Eq	-	Sales Y/Y TTM	-67.75%	Profit Margin	-696.19%	Recom	3.00	Target Price	4.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	98.19%	Payout	-	Rel Volume	0.26	Prev Close	2.94
Sales Surprise	-29.17%	EPS Surprise	0.90%	Sales Q/Q	-69.38%	Earnings	Feb 15 AMC	Avg Volume	247.82K	Price	2.94
SMA20	-1.28%	SMA50	-30.15%	SMA200	-75.98%	Trades		Volume	49,389	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-21	Downgrade	Alliance Global Partners	Buy → Neutral	$2.60 → $2.40
Oct-08-20	Initiated	BTIG Research	Buy	$2.50
Nov-26-19	Downgrade	Janney	Buy → Neutral
Aug-01-19	Downgrade	Alliance Global Partners	Buy → Neutral
Jul-31-19	Downgrade	Janney	Buy → Neutral
Jul-31-19	Downgrade	H.C. Wainwright	Buy → Neutral
May-16-19	Initiated	Alliance Global Partners	Buy	$5
Mar-08-19	Reiterated	H.C. Wainwright	Buy	$14 → $11
Jun-01-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
May-30-18	Reiterated	H.C. Wainwright	Buy	$8.50 → $14
May-29-18	Reiterated	WBB Securities	Strong Buy	$12 → $20
Mar-29-18	Reiterated	H.C. Wainwright	Buy	$8 → $8.50
Jan-29-18	Initiated	Goldman	Neutral	$5.20
Oct-18-17	Initiated	H.C. Wainwright	Buy	$8
Mar-15-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Nov-10-16	Resumed	Leerink Partners	Mkt Perform	$5
Nov-02-16	Reiterated	Cantor Fitzgerald	Buy	$10 → $9
Jul-20-16	Upgrade	WBB Securities	Buy → Strong Buy	$11 → $12
Jun-22-16	Upgrade	WBB Securities	Speculative Buy → Buy	$11
Apr-12-16	Reiterated	Canaccord Genuity	Buy	$13 → $12

Show Previous Ratings

Apr-11-24 04:05PM	T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity (GlobeNewswire)
Mar-28-24 09:00AM	T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. (GlobeNewswire)
Mar-20-24 07:30AM	T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates (GlobeNewswire) -10.89%
Mar-19-24 09:00AM	T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates (GlobeNewswire) -11.20%
Mar-18-24 09:00AM	T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel (GlobeNewswire) -5.98%
03:16PM	Loading…
Mar-12-24 03:16PM	TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance (InvestorPlace)
09:00AM	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement (GlobeNewswire)
Feb-16-24 09:29AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.71%
06:08AM	Q4 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 04:06PM	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:04PM	T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity (GlobeNewswire)
04:02PM	T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia (GlobeNewswire)
Feb-12-24 12:12PM	T2 Biosystems Receives 510(K) Clearance for Its Bacteria Panel (InvestorPlace) +32.72%
09:00AM	T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel (GlobeNewswire)
Feb-07-24 04:05PM	T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024 (GlobeNewswire)
09:00AM	Loading…
09:00AM	U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize (GlobeNewswire)
Jan-18-24 09:00AM	T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients (GlobeNewswire)
Jan-03-24 09:00AM	T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing (GlobeNewswire) +13.31%
Nov-15-23 07:24AM	T2 Biosystems: Q3 Earnings Snapshot (Associated Press Finance)
Nov-03-23 09:00AM	T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire) -7.99%
Nov-01-23 01:02PM	TTOO Stock Alert: T2 Biosystems Regains Nasdaq Compliance (InvestorPlace)
09:00AM	T2 Biosystems Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Oct-24-23 04:05PM	T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference (GlobeNewswire) +9.50%
Oct-23-23 09:00AM	T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement (GlobeNewswire)
Oct-16-23 08:47AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2023 Earnings Call Transcript (Insider Monkey) -11.59%
Oct-13-23 12:29PM	Why Is T2 Biosystems (TTOO) Stock Down 48% Today? (InvestorPlace) -52.87%
12:09PM	Why Shares of T2 Biosystems Are Falling Friday (Motley Fool)
Oct-12-23 04:05PM	T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates (GlobeNewswire) -43.87%
04:02PM	T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii (GlobeNewswire)
12:09PM	TTOO Stock Alert: T2 Biosystems Announces Reverse Stock Split (InvestorPlace)
09:00AM	Loading…
09:00AM	T2 Biosystems Announces Reverse Stock Split Effective Today (GlobeNewswire)
Oct-06-23 04:07PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire) +35.67%
10:04AM	Dear TTOO Stock Fans, Mark Your Calendars for Oct. 12 (InvestorPlace)
07:30AM	T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains? (Entrepreneur: Stocks)
Oct-05-23 04:05PM	T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023 (GlobeNewswire)
Sep-19-23 09:00AM	T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel (GlobeNewswire) -26.13%
Sep-15-23 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire) +6.08%
Sep-11-23 03:52PM	The Fun Is Over for TTOO Stock At Least for Now (InvestorPlace) -14.11%
Sep-07-23 04:05PM	T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire) +13.92%
Aug-28-23 08:30AM	T2 Biosystems Praises CDCs Actions Aimed at Optimizing U.S. Hospital Sepsis Programs (GlobeNewswire) -8.84%
Aug-24-23 12:35PM	Is T2 Biosystems a Hidden Gem or a Value Trap? An In-Depth Analysis (GuruFocus.com) -26.35%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE) +51.56%
Aug-14-23 12:38PM	4 Meme Stocks to Sell Before They Die (InvestorPlace) +15.42%
Aug-10-23 11:11AM	T2 Biosystems (TTOO) Stock Is Becoming the Next Mullen (InvestorPlace)
Aug-09-23 06:10PM	3 Meme Stocks to Sell in August Before They Crash and Burn (InvestorPlace) +10.48%
08:30AM	T2 Biosystems Regains Compliance with Nasdaqs Market Value of Listed Securities Requirement (GlobeNewswire)
08:00AM	Is TTOO Stock Really Worth $5? Or Just 5 Cents? (InvestorPlace)
06:32AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 07:42AM	Q2 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents) +26.69%
Aug-07-23 04:22PM	T2 Biosystems: Q2 Earnings Snapshot (AP Finance)
04:05PM	T2 Biosystems Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 09:29PM	GSA Capital Partners LLP Acquires Stake in T2 Biosystems Inc (GuruFocus.com) +27.16%
08:30AM	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements (GlobeNewswire)
Jul-28-23 08:30AM	T2 Biosystems to Attend Upcoming Investor Conferences (GlobeNewswire)
Jul-24-23 04:05PM	T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire) -6.36%
Jul-21-23 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)
Jul-20-23 08:30AM	T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test (GlobeNewswire)
Jul-12-23 03:59PM	7 Doomed Stocks Destined for Disaster (InvestorPlace) -15.74%
08:30AM	T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-06-23 08:00AM	T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity (GlobeNewswire) +12.16%
Jun-09-23 09:15AM	T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use (GlobeNewswire) -14.42%
Jun-05-23 09:00AM	T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test (GlobeNewswire) -31.37%
May-30-23 09:00AM	T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History (GlobeNewswire) +42.39%
May-23-23 11:12PM	Q1 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents) -38.51%
08:50AM	T2 Biosystems: Q1 Earnings Snapshot (AP Finance)
08:05AM	T2 Biosystems Announces First Quarter 2023 Financial Results (GlobeNewswire)
08:01AM	T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program (GlobeNewswire)
08:00AM	T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel (GlobeNewswire)
May-22-23 08:15AM	T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 23, 2023 (GlobeNewswire)
May-19-23 09:22AM	WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens (Newsfile)
May-17-23 04:05PM	T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 22, 2023 (GlobeNewswire)
May-15-23 04:05PM	T2 Biosystems Postpones Reporting of First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 04:05PM	T2 Biosystems to Report First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire) -6.36%
Apr-26-23 08:30AM	T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference (GlobeNewswire)
Apr-19-23 03:39PM	T2 Biosystems, Inc.'s (NASDAQ:TTOO) Low P/S No Reason For Excitement (Simply Wall St.)
Apr-05-23 08:00AM	T2 Biosystems Announces Webinar and White Paper Highlighting T2Candida Panel Clinical Data and Best Practices (GlobeNewswire)
Mar-23-23 09:00AM	T2 Biosystems Affirms Plans to Add Candida Auris Detection to the FDA-Cleared T2Candida Panel (GlobeNewswire) -7.97%
Mar-14-23 11:12AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2022 Earnings Call Transcript (Insider Monkey)
07:24AM	Q4 2022 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-13-23 04:05PM	T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 08:00AM	T2 Biosystems to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023 (GlobeNewswire)
Feb-15-23 07:30AM	T2 Biosystems Announces Pricing of $12 Million Public Offering (GlobeNewswire) -23.19%
Feb-14-23 05:29AM	T2 Biosystems Touts Positive Results From T2Biothreat Panel Study (Benzinga) -22.86%
Feb-13-23 04:19PM	T2 Biosystems Announces Proposed Public Offering (GlobeNewswire)
04:01PM	T2 Biosystems Announces Positive Results upon Completion of U.S. Clinical Evaluation for the T2Biothreat Panel (GlobeNewswire)
01:59PM	The 7 Best Stocks to Short This Week (InvestorPlace)
Feb-06-23 04:05PM	T2 Biosystems Advances to the Phase 2 in HHS and the Steven and Alexandra Cohen Foundations LymeX Diagnostics Prize (GlobeNewswire) +5.71%
Feb-03-23 04:30PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)
Jan-23-23 04:30PM	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Dec-28-22 09:00AM	T2 Biosystems Announces Extension of Multiyear Innovative Technology Contract with Vizient, Inc. (GlobeNewswire) +7.55%
Dec-08-22 08:28AM	T2 Biosystems Highlights Peer-Reviewed Article Linking COVID-19 and Sepsis and Underscoring CDC Call for Adoption of Early and Accurate Microbial Diagnosis to Guide Targeted Initial Antimicrobial Therapy (GlobeNewswire)
Nov-16-22 05:08AM	T2 Biosystems Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-10-22 04:05PM	T2 Biosystems Announces Third Quarter 2022 Financial Results (GlobeNewswire) +5.11%
04:04PM	T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement (GlobeNewswire)
Nov-09-22 04:05PM	T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-07-22 08:30AM	HHS and the Cohen Foundation Name T2 Biosystems a Phase 1 Winner in LymeX Diagnostics Prize (GlobeNewswire)
Nov-01-22 08:30AM	T2 Biosystems Regains Compliance with Nasdaqs Minimum Bid Price Rule (GlobeNewswire)
Oct-31-22 05:57PM	T2 Biosystems to Report Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-20-22 09:05AM	T2 Biosystems Initiates Studies to Add Acinetobacter Baumannii to the FDA-Cleared T2Bacteria Panel (GlobeNewswire)
Oct-14-22 08:30AM	T2 Biosystems Highlights Multiple New Studies Demonstrating Improved Rapid Detection Across Several Patient Populations (GlobeNewswire) -9.02%

T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CR Group L.P.	10% Owner	Sep 28 '23	Sale	0.16	7,148,945	1,125,959	0	Sep 29 04:30 PM
CR Group L.P.	10% Owner	Sep 27 '23	Sale	0.19	5,981,202	1,145,998	571,796	Sep 29 04:30 PM
CR Group L.P.	10% Owner	Sep 26 '23	Sale	0.20	5,392,920	1,082,359	1,050,192	Sep 28 04:30 PM
CR Group L.P.	10% Owner	Sep 25 '23	Sale	0.25	250,000	62,500	1,481,535	Sep 27 05:53 PM
CR Group L.P.	10% Owner	Sep 22 '23	Sale	0.26	5,079,344	1,314,534	1,501,531	Sep 26 05:15 PM
CR Group L.P.	10% Owner	Sep 21 '23	Sale	0.30	6,338,211	1,904,632	1,907,794	Sep 25 08:30 PM
CR Group L.P.	10% Owner	Sep 20 '23	Sale	0.31	7,753,710	2,408,302	2,414,745	Sep 22 04:15 PM
CR Group L.P.	10% Owner	Sep 19 '23	Sale	0.37	10,401,466	3,806,937	3,034,912	Sep 21 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TTOO

T2 Biosystems Inc

Upgrade your FINVIZ experience